Li J, Xu W, Xu L, Liang Z. Hip resurfacing for the treatment of developmental dysplasia of the hip. Orthopedics, 2008 Dec;31(12):1199.（IF 0.594）
Li J, Xu W, Xu L, Liang Z. Hip resurfacing arthroplasty for ankylosing spondylitis. J Arthroplasty. 2009 Dec;24(8):1285-91.(IF 1.787)
Zhang X, Xu W, Li J, Fang Z, Chen K. Large-diameter metal-on-metal cementless total hip arthroplasty in the elderly. Orthopedics. 2010 Dec 1;33(12):872.（IF 0.594）
Chen R, Yao L, Meng T, Xu W. The association between seven ERAP1 polymorphisms and Ankylosing Spondylitis susceptibility: a meta-analysis involving 8,530 cases and 12,449 controls. Rheumatol Int. 2012 Apr; 32(4):909-14. (IF 1.493)
Xu WD, Li J, Zhou ZH, Wu YS, Li M. Results of hip resurfacing for developmental dysplasia of the hip of Crowe type I and II. Chin Med J (Engl).2008 Aug5;121(15):1379-83.（IF 0.952）
Wang JG, Xu WD (Coordinate first author), Zhai WT, Li Y, Hu JW, Hu B, Li M, Zhang L, Guo W, Zhang JP,Wang LH, Jiao BH. Disorders in angiogenesis and redox pathways are main factors contributing to the progression of rheumatoid arthritis: a comparative proteomic study. Arthritis Rheum. 2012 Apr;64(4):993-1004.（IF 7.477）
Xu L, Sun Q, Jiang S, Li J, He C, Xu W.Changes in gene expression profiles of the hip joint ligament of patients with ankylosing spondylitis revealed by DNA chip.Clin Rheumatol. 2012 Oct; 31(10):1479-91. (IF 2.0)
Chen B, Li D, Xu W.Association of ankylosing spondylitis with HLA-B27 and ERAP1: pathogenic role of antigenic peptide.Med Hypotheses. 2013 Jan; 80(1):36-8. (IF 1.15)
Sun QW, Jiang SM, Yang K, Zheng JM, Zhang L, Xu WD. Apigenin enhances the cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand in human rheumatoid arthritis fibroblast-like synoviocytes, Mol Biol Rep, 39(5), 5529-5535, 2012 (IF 2.929)
Wang C, Xu W (Coordinate first author), He S, Gu S, Zhao Y, Zhang J, et al. Differences in postoperative quality of life between adolescent patients with idiopathic scoliosis residing in urban and rural environments. Spine (Phila Pa 1976). 2010 Mar 15;35(6):652-6. (IF 2.159)
Yuan HF, Xu WD, Hu HY. Young Chinese doctors and the pressure of publication. Lancet. 2013 Feb 2; 381(9864):e4 (IF 39.06)
Zheng W, Li J, Zhao J, Liu D, Xu W. Development of a Valid Simplified Chinese Version of the Oxford Hip Score in Patients With Hip Osteoarthritis. Clin Orthop Relat Res. 2014 May;472(5):1545-51. (IF 2.787)
Li J, Zheng W, Zhao J, Liu D, Xu W. Total Hip Arthroplasty for Femoral Neck Fractures in Patients with Neurological Conditions using Large-Diameter Metal-on-metal Prosthesis. Indian J Orthop. 2014 Nov;48(6):605-11. (IF 0.737)
He C, Li J, Xu W. Mutations in the B30.2 domain of pyrin and the risk of ankylosing spondylitis in the Chinese Han population: a case-control study. Immunol Lett. 2014 Nov;162(1 Pt A):49-52. (IF 2.337)
Zhao J, Zheng W, Zhang C, Li J, Liu D, Xu W. Radiographic Hip Involvement in Ankylosing Spondylitis: Factors Associated with Severe Hip Diseases. J Rheumatol. 2014 Nov 1. (IF 3.173)
Qin Y, He LD, Sheng ZJ, Yong MM, Sheng YS, Wei Dong X, Wen Wen T, Ming ZY. Increased CCL19 and CCL21 levels promote fibroblast ossification in ankylosing spondylitis hip ligament tissue. BMC Musculoskelet Disord. 2014 Sep 26;15:316. (IF 1.898)
Zhao J, Li J, Zheng W, Liu D, Sun X, Xu W. Low body mass index and blood loss in primary total hip arthroplasty: results from 236 consecutive ankylosing spondylitis patients. Biomed Res Int. 2014;2014:742393. (IF 2.706)
Xu WD, Yang XY, Li DH, Zheng KD, Qiu PC, Zhang W, Li CY, Lei KF, Yan GQ, Jin SW, Wang JG. Up-regulation of fatty acid oxidation in the ligament as a contributing factor of ankylosing spondylitis: A comparative proteomic study. J Proteomics. 2015 Jan 15;113:57-72. (IF 3.929)
Yang MY, Yuan HF, Miao MY, Xu WD. The osteogenic potential of ligament fibroblasts is greater in patients with ankylosing spondylitis than in patients with osteoarthritis. Z Rheumatol. (IF 0.456)
仁心醫師評審